HK Pharma Stocks Rose; WUXI XDC And WUXI AppTec Up 7%; HBM Holdings Up 6%; Hengrui Pharma And JW Therap Up 4%

TigerOct 27, 2025 1:44 AM

View all comments（0）



On October 27, Hong Kong Stock Market's innovative pharmaceutical concept stocks rose at market open, with WUXI XDC and WUXI AppTec up 7%; HBM Holdings up 6%; Hengrui Pharma and JW Therap up 4%; TIGERMED, Junshi and RemeGen increased more than 3%.

On the news front, Wuxi Biologics recently announced that for the first three quarters of 2025, it achieved operating revenue of RMB 32.86 billion, a year-on-year increase of 18.6%, and a 22.5% year-on-year increase in revenue from continuing operations. Net profit attributable to shareholders of the listed company was RMB 12.076 billion, up 84.84% year-on-year. The company expects the revenue from continuing operations to resume double-digit growth in 2025, with growth rates adjusted from 13-17% to 17-18%. The company anticipates full-year total revenue to be adjusted from RMB 42.5-43.5 billion to RMB 43.5-44.0 billion. The company will focus on its core CRDMO business and continue to improve production and operational efficiency.

By the end of September 2025, Wuxi Biologics had orders in hand for continuing operations totaling RMB 59.88 billion, up 41.2% year-on-year. For the first three quarters of 2025, the company's revenue from continuing operations was RMB 32.45 billion, with revenue from US clients reaching RMB 22.15 billion, up 31.9% year-on-year; revenue from European clients amounted to RMB 3.84 billion, up 13.5% year-on-year; revenue from Chinese clients was RMB 5.04 billion, up 0.5% year-on-year; and revenue from clients in other regions was RMB 1.42 billion, up 9.2% year-on-year.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

US Stocks Mixed as Dow Drops 160 Points; Tech Stocks Lead, Meta Rises 4.5%

The top leaders of China and the U.S. met in the United States, alongside reports that U.S.-Iran negotiations were seeking to reopen the Strait of Hormuz. U.S. stocks recovered part of their losses, with technology stocks leading the gains. At the close, the Dow Jones Industrial Average fell 0.31% to 51,349.98; the Nasdaq Composite Index rose 0.01% to 26,939.37; and the S&P 500 Index dipped 0.02% to 7,704.13.

Meta Stock Forecast: Muse Monetization Path Is Key as JPMorgan Raises Price Target to $920; Can Stock Hit Record High?

On September 24, Eastern Time, Meta Platforms (META) reached an intraday price of $777.89, hitting a nearly one-year high. Following the Meta Connect event, JPMorgan raised its price target on the company from $820 to $920 while maintaining an Overweight rating. The core reason is that the monetization path for Muse is becoming increasingly clear, leaving the bank more optimistic about Meta's growth potential beyond advertising.

Oracle Tumbles 7% as Project Jupiter Data Center Force Majeure Notice Sparks Delay Concerns

On September 24, Oracle (ORCL) fell as much as 5% in pre-market trading and dropped over 7% after the market opened. Sparking market concerns was a force majeure notice issued by the company regarding Project Jupiter, a large-scale data center in New Mexico. Investors' focus is shifting from massive AI orders to delivery timelines and capital recovery. According to Bloomberg, Oracle has sent a formal notice to developer Stack Infrastructure, seeking to delay payments if the project fails to become operational as planned in 2028. This move does not imply exiting its position as the primary tenant, nor does it mean a payment waiver has been granted. Oracle maintained that the project is proceeding according to schedule, but did not specifically address the notice itself.

Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?

TradingKey - At the Connect 2026 conference held from September 23 to 24, Meta (META) unveiled the Ray-Ban Meta Audio, third-generation Ray-Ban Meta, and Meta VR Glasses, while upgrading the Meta Ray-Ban Display. The company also announced the integration of its personal AI agent, Muse, into its AI glasses, expanding its product scope from mobile phones and social apps to wearable devices.

The Week Ahead: US-China Summit in Washington, Costco Earnings and Fed Rate Path in Focus

TradingKey - During the week of September 21 to 25, Eastern Time, the US stock market will focus on the meeting between Chinese and US leaders, the Federal Reserve's policy outlook, and economic data such as US new home sales and durable goods orders.

Featured Tools